查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2007982

鴉片類藥物使用障礙 (OUD) 市場：按產品類型、給藥途徑、劑型、性別、品牌、年齡層、類型、適應症、分銷管道和地區分類

Opioid Use Disorder Market, By Product Type, By Route of Administration, By Dosage Form, By Availability, By Brand, By Age Group, By Type, By Indication, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

據估計，2026年鴉片類藥物使用障礙（OUD）市場規模為63.034億美元，預計到2033年將達到98.602億美元。預計從2026年到2033年，該市場將以9.4%的複合年成長率成長。

報告範圍 報告詳情
基準年： 2025 2026年市場規模： 63.034億美元
歷史數據時期： 2020年至2024年 預測期： 2026年至2033年
2026年至2033年預測期間的複合年成長率： 9.40% 2033年市場規模預測： 98.602億美元

全球鴉片類藥物使用障礙 (OUD) 市場是一個至關重要的醫療保健領域，它正努力應對當今最緊迫的公共衛生危機之一。 OUD 的特徵是儘管存在有害後果，仍會強迫性地使用鴉片類藥物，這是一種慢性疾病。 OUD 影響著全球數百萬人，並給醫療保健系統、家庭和社區帶來沉重的社會經濟負擔。該市場涵蓋多種治療介入措施，包括美沙酮、Buprenornhine和納曲酮等輔助性治療(MAT)，以及綜合行為療法和支持治療性介入。由於全球數十萬人死於鴉片類藥物過量，成癮率持續上升，對有效治療方案的需求正在顯著成長。

受循證治療方法認知度提高、政府促進醫療服務可及性的舉措以及對成癮作為一種需要專業干預的合法疾病的污名化現象的減少等因素的推動，該市場正經歷顯著成長。醫療服務提供者、製藥公司和政策制定者正攜手合作，開發創新治療方法，擴大醫療服務覆蓋範圍，並實施減少危害的策略。數位健康科技、遠端醫療平台和個人化治療方案的整合，正在進一步改變產業格局，為患者參與和最佳化治療方案以應對這一複雜疾病提供了新的機會。

市場動態

全球鴉片類藥物使用障礙（OUD）市場的主要驅動力是全球鴉片類藥物成癮盛行率的激增，處方鴉片類藥物濫用和非法藥物使用在已開發國家和開發中國家均已達到流行病的程度。政府措施和政策改革，例如擴大醫療補助覆蓋範圍和取消藥物成癮治療（MAT）的預先核准要求，正在顯著推動循證治療方法的普及，從而顯著促進市場成長。隨著人們對成癮的認知從道德缺陷轉變為可治療的疾病，社會歧視正在減少，越來越多的人開始尋求專業協助。治療服務的技術進步，例如遠端醫療平台、行動醫療應用程式和遠端監測系統，提高了治療的可近性和依從性，尤其是在服務不足的農村地區。

然而，該市場面臨許多限制因素，包括圍繞成癮治療的持續污名化、某些地區醫療基礎設施不足以及綜合治療項目保險覆蓋範圍有限。監管的複雜性和特定藥物嚴格的處方要求對醫療服務提供者和患者都構成了障礙。合格的成癮專家和治療機構的匱乏，尤其是在遍遠地區，嚴重限制了人們獲得醫療服務的機會。此外，長期治療計畫的高成本以及不同醫療體系之間缺乏標準化的治療通訊協定，也對市場擴張構成挑戰。

儘管如此，透過開發新型治療方法，例如長效注射劑和預防濫用藥物，仍存在巨大的成長機會。日益重視將醫療和行為健康服務結合的綜合護理模式，也顯示了其巨大的成長潛力。官民合作關係以及對成癮研究、開發和治療基礎設施投入的增加，為市場擴張提供了一個有希望的途徑。

本次調查的主要特點。

  • 本報告對全球鴉片類藥物使用障礙 (OUD) 市場進行了詳細分析，以 2025 年為基準年，給出了預測期 (2026-2033) 的市場規模和復合年成長率 (%)。
  • 本報告指出了各個細分市場的潛在商機，並說明了該市場中具有吸引力的投資提案矩陣。
  • 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的關鍵見解。
  • 本報告根據以下參數分析了全球鴉片類藥物使用障礙 (OUD) 市場的主要參與者：公司概況、產品系列、主要亮點、財務績效和策略。
  • 透過利用本報告中提出的見解，企業行銷負責人和經營團隊可以就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 本報告面向該產業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過分析全球鴉片類藥物使用障礙 (OUD) 市場中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章：研究目標與前提條件

  • 研究目標
  • 前提
  • 簡稱

第2章 市場範圍

  • 報告摘要
    • 市場定義和範圍
  • 執行摘要

第3章：市場動態、監管與趨勢分析

  • 市場動態
  • 促進因素
  • 阻礙因素
  • 機會
  • 影響分析
  • 主要進展
  • 法規環境
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購趨勢
  • 產業趨勢

第4章 全球鴉片類藥物使用障礙（OUD）市場：依產品類型分類，2021-2033年

  • Buprenorphine
  • Naloxone
  • Naltrexone
  • 複方製劑
  • Methadone

第5章 全球鴉片類藥物使用障礙（OUD）市場：依給藥途徑分類，2021-2033年

  • 腸外
  • 口服
  • 其他

第6章 全球鴉片類藥物使用疾患（OUD）市場：依劑型分類，2021-2033年

  • 注射藥物
  • 舌下膜
  • 舌下或頰粘膜
  • 藥片
  • 懸浮液
  • 其他

第7章 全球鴉片類藥物使用障礙（OUD）市場：按性別分類的供應情況，2021-2033年

  • 處方
  • OTC

第8章 全球鴉片類藥物使用障礙（OUD）市場：依品牌分類，2021-2033年

  • Sublocade
  • Suboxone
  • Brixadi
  • Vivitrol
  • Zubsolv
  • NARCAN
  • 其他

第9章 全球鴉片類藥物使用障礙（OUD）市場：按年齡分類，2021-2033年

  • 成人
  • 兒童

第10章 全球鴉片類藥物使用障礙（OUD）市場：按類型分類，2021-2033年

  • 品牌
  • 非專利的

第11章 全球鴉片類藥物使用障礙（OUD）市場：依適應症分類，2021-2033年

  • 鴉片類成癮
  • 疼痛管理
  • 急性
  • 慢性的

第12章 全球鴉片類藥物使用障礙（OUD）市場：依通路分類，2021-2033年

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第13章 全球鴉片類藥物使用障礙（OUD）市場：依地區分類，2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 亞太其他地區
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第14章 競爭格局

  • Indivior
  • Braeburn
  • Camurus
  • Alkermes
  • Emergent BioSolutions
  • Orexo
  • Hikma Pharmaceuticals
  • Dr Reddy's Laboratories
  • Alvogen
  • Sun Pharmaceutical Industries
  • Amneal Pharmaceuticals
  • Viatris
  • Teva Pharmaceuticals
  • Sandoz
  • Kaleo

第15章 分析師建議

  • 機會
  • 分析師意見
  • 連貫的機會地圖

第16章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI4597

Opioid Use Disorder Market is estimated to be valued at USD 6,303.4 Mn in 2026 and is expected to reach USD 9,860.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.4% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 6,303.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 9.40% 2033 Value Projection: USD 9,860.2 Mn

The global opioid use disorder market represents a critical healthcare segment addressing one of the most pressing public health crises of the modern era. Opioid use disorder is characterized as a chronic medical condition involving the compulsive use of opioids despite harmful consequences, affecting millions of individuals worldwide and imposing substantial socioeconomic burdens on healthcare systems, families, and communities. The market encompasses various therapeutic interventions including medication-assisted treatment (MAT) options such as methadone, buprenorphine, and naltrexone, alongside comprehensive behavioral therapies and support services. With opioid-related overdoses claiming hundreds of thousands of lives globally and addiction rates continuing to escalate, the demand for effective treatment solutions has intensified significantly.

The market has witnessed substantial growth driven by increasing awareness about evidence-based treatments, government initiatives promoting accessible healthcare, and the destigmatization of addiction as a legitimate medical condition requiring professional intervention. Healthcare providers, pharmaceutical companies, and policymakers are collectively working to develop innovative treatment modalities, expand access to care, and implement harm reduction strategies. The integration of digital health technologies, telemedicine platforms, and personalized treatment approaches has further transformed the landscape, offering new opportunities for patient engagement and treatment optimization in addressing this complex disorder.

Market Dynamics

The global opioid use disorder market is primarily driven by the escalating prevalence of opioid addiction worldwide, with prescription opioid misuse and illicit drug consumption reaching epidemic proportions across developed and developing nations. Government initiatives and policy reforms promoting evidence-based treatment approaches, including expanded Medicaid coverage and the elimination of prior authorization requirements for MAT, have significantly boosted market growth. The increasing recognition of addiction as a treatable medical condition rather than a moral failing has reduced stigma and encouraged more individuals to seek professional help. Technological advancements in treatment delivery, including telemedicine platforms, mobile health applications, and remote monitoring systems, have improved accessibility and treatment adherence, particularly in underserved rural areas.

However, the market faces substantial restraints including persistent stigma surrounding addiction treatment, limited healthcare infrastructure in certain regions, and inadequate insurance coverage for comprehensive treatment programs. Regulatory complexities and stringent prescribing requirements for certain medications create barriers for healthcare providers and patients. The shortage of qualified addiction specialists and treatment facilities, particularly in rural areas, significantly limits access to care. Additionally, the high cost of long-term treatment programs and the lack of standardized treatment protocols across different healthcare systems pose challenges to market expansion.

Nevertheless, significant opportunities exist through the development of novel therapeutic interventions, including long-acting injectable formulations and abuse-deterrent medications. The growing emphasis on integrated care models combining medical treatment with behavioral health services presents substantial growth potential. Public-private partnerships and increased funding for addiction research and treatment infrastructure development offer promising avenues for market expansion.

Key Features of the Study

  • This report provides in-depth analysis of the global opioid use disorder market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global opioid use disorder market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Indivior, Braeburn, Camurus, Alkermes, Emergent BioSolutions, Orexo, Hikma Pharmaceuticals, Dr Reddy's Laboratories, Alvogen, Sun Pharmaceutical Industries, Amneal Pharmaceuticals, Viatris, Teva Pharmaceuticals, Sandoz, and Kaleo
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global opioid use disorder market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global opioid use disorder market

Market Segmentation

  • Product Type Insights (Revenue, USD Mn, 2021 - 2033)
    • Buprenorphine
    • Oral
    • Parenteral
    • Others
    • Naloxone
    • Parenteral
    • Others
    • Naltrexone
    • Oral
    • Parenteral
    • Combination Drugs
    • Methadone
  • Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
    • Parenteral
    • Extended-release Injection for Subcutaneous
    • Intramuscular
    • Oral
    • Sublingual Tablet
    • Sublingual Film
    • Suspension
    • Others
  • Dosage Form Insights (Revenue, USD Mn, 2021 - 2033)
    • Injections
    • Sublingual film
    • Sublingual or Buccal
    • Tablet
    • Suspension
    • Others
  • Availability Insights (Revenue, USD Mn, 2021 - 2033)
    • Prescription
    • Over the Counter
  • Brand Insights (Revenue, USD Mn, 2021 - 2033)
    • Sublocade
    • Suboxone
    • Brixadi
    • Vivitrol
    • Zubsolv
    • NARCAN
    • Others
  • Age Group Insights (Revenue, USD Mn, 2021 - 2033)
    • Adult
    • Children
  • Type Insights (Revenue, USD Mn, 2021 - 2033)
    • Branded
    • Generic
  • Indication Insights (Revenue, USD Mn, 2021 - 2033)
    • Opioid Addiction
    • Pain Management
    • Acute
    • Chronic
  • Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Indivior
    • Braeburn
    • Camurus
    • Alkermes
    • Emergent BioSolutions
    • Orexo
    • Hikma Pharmaceuticals
    • Dr Reddy's Laboratories
    • Alvogen
    • Sun Pharmaceutical Industries
    • Amneal Pharmaceuticals
    • Viatris
    • Teva Pharmaceuticals
    • Sandoz
    • Kaleo

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Opioid Use Disorder Market, By Product Type
    • Global Opioid Use Disorder Market, By Route of Administration
    • Global Opioid Use Disorder Market, By Dosage Form
    • Global Opioid Use Disorder Market, By Availability
    • Global Opioid Use Disorder Market, By Brand
    • Global Opioid Use Disorder Market, By Age Group
    • Global Opioid Use Disorder Market, By Type
    • Global Opioid Use Disorder Market, By Indication
    • Global Opioid Use Disorder Market, By Distribution Channel
    • Global Opioid Use Disorder Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Opioid Use Disorder Market, By Product Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Buprenorphine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
      • Oral
      • Parenteral
      • Others
  • Naloxone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
      • Parenteral
      • Others
  • Naltrexone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
      • Oral
      • Parenteral
  • Combination Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Methadone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Opioid Use Disorder Market, By Route of Administration, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
      • Extended-release Injection for Subcutaneous
      • Intramuscular
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
      • Sublingual Tablet
      • Sublingual Film
      • Suspension
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Opioid Use Disorder Market, By Dosage Form, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Injections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Sublingual film
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Sublingual or Buccal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Tablet
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Suspension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Opioid Use Disorder Market, By Availability, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Prescription
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Over the Counter
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Opioid Use Disorder Market, By Brand, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Sublocade
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Suboxone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Brixadi
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Vivitrol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Zubsolv
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • NARCAN
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

9. Global Opioid Use Disorder Market, By Age Group, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Children
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

10. Global Opioid Use Disorder Market, By Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Branded
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Generic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

11. Global Opioid Use Disorder Market, By Indication, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Opioid Addiction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Pain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Acute
  • Chronic

12. Global Opioid Use Disorder Market, By Distribution Channel, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

13. Global Opioid Use Disorder Market, By Region, 2021 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Channel, 2021 - 2033, Value (USD Mn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Channel, 2021 - 2033, Value (USD Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

14. Competitive Landscape

  • Indivior
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Braeburn
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Camurus
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Alkermes
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Emergent BioSolutions
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Orexo
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hikma Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dr Reddy's Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Alvogen
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sun Pharmaceutical Industries
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amneal Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Viatris
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sandoz
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Kaleo
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

15. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

16. References and Research Methodology

  • References
  • Research Methodology
  • About us